Clinical trial
Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and…
NCT00422253 · Bayside Health, Other · Completed
Key facts
| NCT number | NCT00422253 |
|---|---|
| Title | Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and Obese Humans |
| Official title | Will Reduction in Dietary Advanced Glycation End- Products Reduce Chronic Low Grade Inflammation and Improve Insulin Sensitivity in Overweight and Obese Humans |
| Lead sponsor | Bayside Health, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 2 Diabetes, Insulin Resistance, Obesity |
| Intervention type | Behavioral |
| Interventions | dietary intervention |
| Enrollment | 27 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Jan 15, 2007 |
| Last update posted | Dec 16, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: